Date Name Title Filing Type Shares Traded Price Total Held
Oct 30, 2015
Director, President Regeneron Laboratori
Director, President Regeneron Laboratori Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 182,818 -- --
Dec 16, 2014
Director, President Regeneron Laboratori
Director, President Regeneron Laboratori Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 3,264 -- --
Aug 27, 2014
Director, President Regeneron Laboratori
Director, President Regeneron Laboratori Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 5,720 -- --
Mar 06, 2014
Director, President Regeneron Laboratori
Director, President Regeneron Laboratori Form 4 Bona fide gift 23,367 -- --
Feb 11, 2014
Director, President Regeneron Laboratori
Director, President Regeneron Laboratori Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 189,463 -- --
Dec 19, 2013
Director, President Regeneron Laboratori
Director, President Regeneron Laboratori Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 4,705 -- --
Dec 12, 2013
Director, Pres Regeneron Labs
Director, Pres Regeneron Labs Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 9,599 -- --
May 06, 2013
Director, President Regeneron Laboratori
Director, President Regeneron Laboratori Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 192,308 -- --
Dec 19, 2012
Director, EVP CSO Pres Regen Res Labs
Director, EVP CSO Pres Regen Res Labs Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 10,537 -- --
Dec 19, 2012
Director, EVP CSO Pres Regen Res Labs
Director, EVP CSO Pres Regen Res Labs Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 17,182 -- --

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.